BioMarin Pharmaceutical Inc. buy Citigroup Inc.
Start price
19.05.26
/
50%
€42.91
Target price
19.05.27
€64.43
Performance (%)
20.72%
Price
10.07.26
€51.80
Summary
This prediction is currently active. The BUY prediction by Citigroup_Inc_ currently has a performance of 20.72%. This prediction currently runs until 19.05.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | 0.739% | 0.739% |
| iShares Core DAX® | -1,60 % | 1,52 % |
| iShares Nasdaq 100 | 1,43 % | 1,16 % |
| iShares Nikkei 225® | 1,11 % | 1,73 % |
| iShares S&P 500 | 0,53 % | 2,97 % |
Comments by Citigroup_Inc_ for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical (BMRN) is now covered by Citigroup Inc.. They set a "buy" rating and a $75.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat